LT-IVAX is a live virus vaccine of chicken tissue culture origin containing a carefully selected fowl laryngotracheitis virus
strain modified by passage in tissue culture. Because of the highly modified character of this vaccine, it does not offer the same
degree of protection usually obtained from more virulent products. This vaccine contains a very mild attenuated virus and there is
no danger of seeding down the premises with laryngotracheitis virus which can spread and cause the disease. Solid and uniform
protection against infectious laryngotracheitis when administered via eye-dro. Safe - more attenuated than CEO vaccines, has not
been associated with vaccine induced outbreaks. Has been shown to not spread from bird to bird in challenge based contact
controlled studies. For vaccination of chickens 4 weeks of age or older as an aid in preventing infectious laryngotracheitis.